Sage Journals: Discover world-class research

Abstract

Hepatitis C virus (HCV) infections are a leading cause of liver disease and liver cancer in the United States. Due to the intersection of substance use disorders and incarceration, HCV prevalence is far higher among criminal legal system-involved individuals than in the general population. To avoid the harms associated with incarceration, increasing efforts have been made to divert people away from jail and prison. Yet, there are few data on the HCV care cascade among people with HCV engaged in alternative-to-incarceration (ATI) programs. Here we provide background on the history of ATI programs in the United States, highlight the importance of engaging people living with HCV in ATI programs, present case examples of programs that have incorporated HCV-specific services, and discuss potential challenges and solutions to scaling up HCV-related services in ATI programs.

Keywords

HCV elimination ATI alternative to incarceration criminal legal system correctional health care

Get full access to this article

View all access options for this article.

References

Ahalt

, Trestman

R. L.

, Rich

J. D.

, Greifinger

R. B.

, & Williams

B. A

. (2013). Paying the price: The pressing need for quality, cost, and outcomes data to improve correctional health care for older prisoners. Journal of the American Geriatrics Society, 61(11), 2013–2019. 10.1111/jgs.12510

Akiyama

M. J

. (2020). Hepatitis C in the criminal justice system: Opportunities for global action in the era of viral hepatitis elimination. BMC Medicine, 18(1), 208. 10.1186/s12916-020-01680-0

Akiyama

M. J.

, Bialek

, & Simonson

. (2025). The carceral-community cascade and HCV elimination. JAMA, 333(5), 369–370. 10.1001/jama.2024.20602

Akiyama

M. J.

, Columbus

, MacDonald

, Jordan

A. O.

, Schwartz

, Litwin

A. H.

, Eckhardt

, & Carmody

. (2019). Linkage to hepatitis C care after incarceration in jail: A prospective, single arm clinical trial. BMC Infectious Diseases, 19(1). 10.1186/s12879-019-4344-1

Akiyama

M. J.

, Ross

, Rimawi

, Fox

, Jordan

A. O.

, Wiersema

, Litwin

A. H.

, Kaba

, & MacDonald

. (2020a). Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study. PLOS One, 15(12), e0242623. 10.1371/journal.pone.0242623

Akiyama

M. J.

, Spaulding

A. C.

, & Rich

J. D

. (2020b). Flattening the curve for incarcerated populations - Covid-19 in jails and prisons. The New England Journal of Medicine, 382(22), 2075–2077. 10.1056/NEJMp2005687

Balchi

, Murphy

, Taxman

F. S.

, & Bhati

. (2019). Findings from the New York City gap analysis project: Alternatives to incarceration report. The Center for Advancing Correctional Excellence, George Mason University. http://criminaljustice.cityofnewyork.us/wp-content/uploads/2020/10/MOCJ-ATI-RNR-Report-2019.pdf.

Baldwin

. (n.d.). Sentencing alternatives to jail and prison. Criminaldefenselawyer.com. https://www.criminaldefenselawyer.com/Sentencing-Alternatives-To-Jail-Time.cfm.

Bhattacharya

, Aronsohn

, Price

, Lo Re ,

III , Heald

, Demisashi

, Durzy

, Davis-Owino

, & Tynes ,

III , American Association for the Study of Liver Diseases–Infectious Diseases Society of America, HCV Guidance Panel. (2023). Hepatitis C guidance 2023 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Clinical Infectious Diseases. 10.1093/cid/ciad319

10.

Buehler

E. D.

, & Kluckow

. (2024). Correctional populations in the United States, 2022—Statistical tables. Bureau of Justice Statistics. Retrieved January 4, 2025, from https://bjs.ojp.gov/library/publications/correctional-populations-united-states-2022-statistical-tables.

11.

Bureau of Justice Statistics. (2024). Community corrections (probation and parole). https://bjs.ojp.gov/topics/corrections/community-corrections.

12.

Davey

, Costello

, Russo

, Davies

, Lalani

H. S.

, Kesselheim

A. S.

, & Rome

B. N

. (2024). Changes in use of hepatitis C direct-acting antivirals after access restrictions were eased by state Medicaid programs. JAMA Health Forum, 5(4), e240302. 10.1001/jamahealthforum.2024.0302

13.

Devall

, Lanier

, & Baker

L. J

. (2022). Painting the current picture: A national report on treatment courts in the United States. National Drug Court Resource Center. https://kffhealthnews.org/wp-content/uploads/sites/2/2023/11/PCP_MentalHealthCourts_Brief_2022_DigitalRelease.pdf.

14.

Fleurence

R. L.

, & Collins

F. S

. (2023). A national hepatitis C elimination program in the United States: A historic opportunity. JAMA, 329(15), 1251–1252. 10.1001/jama.2023.3692

15.

Goldstein

. (2024). Best practice: Promoting infectious disease testing in MA opioid treatment programs. Commonwealth of Massachusetts. https://www.mass.gov/doc/best-practice-promoting-infectious-disease-testing-in-ma-opioid-treatment-programs-pdf/download.

16.

Gunn

R. A.

, Lee

M. A.

, Callahan

D. B.

, Gonzales

, Murray

P. J.

, & Margolis

H. S

. (2005). Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. American Journal of Preventive Medicine, 29(1), 27–33. 10.1016/j.amepre.2005.03.010

17.

Gutkind

, Schackman

B. R.

, Morgan

J. R.

, Leff

J. A.

, Agyemang

, Murphy

S. M.

, Akiyama

M. J.

, Norton

B. L.

, Litwin

A. H.

, & Linas

B. P

. (2020). Cost-effectiveness of hepatitis C virus treatment models for people who inject drugs in opioid agonist treatment programs. Clinical Infectious Diseases, 70(7), 1397–1405. 10.1093/cid/ciz384

18.

Jessa

A.-B.

, French-Marcelin

, Rodriguez

, & Larkin

. (2024). Unlocking potential: The role of community-based alternatives in strengthening public safety. New York State Alternatives to Incarceration and Reentry Coalition. https://www.lac.org/resource/unlocking-potential-the-role-of-community-based-alternatives-in-strengthening-public-safety.

19.

Kamat

, Kondapalli

, Syed

, Price

, Danias

, Gorbenko

, Cantor

, Valera

, Shah

A. K.

, & Akiyama

M. J

. (2023). Access to hepatitis C treatment during and after incarceration in New Jersey, United States: A qualitative study. Life, 13(4), 1033. 10.3390/life13041033

20.

Massachusetts Department of Public Health. (2024). Massachusetts hepatitis C elimination plan. https://www.mass.gov/doc/massachusetts-hepatitis-c-elimination-plan/download.

21.

McLeod

A. M

. (2012). Decarceration courts: Possibilities and perils of a shifting criminal law. Georgetown Law Faculty Publications and Other Works. https://scholarship.law.georgetown.edu/facpub/1276.

22.

Montana Healthcare Foundation. (2019). Montana treatment court report press release. https://mthf.org/news/pr-treatment-courts-report/.

23.

National Treatment Court Resource Center. (2024). Treatment courts across US states/territories (2023). https://ntcrc.org/wp-content/uploads/2024/06/2023_NTCRC_TreatmentCourt_Count_Table.pdf.

24.

New Mexico Legislative Finance Committee. (2017). Program evaluation: Update on New Mexico drug courts. https://www.nmlegis.gov/Entity/LFC/Documents/Program_Evaluation_Reports/Program%20Evaluation%20Update%20on%20New%20Mexico%20Drug%20Courts.pdf.

25.

New York State Division of Criminal Justice Services. (n.d.). Alternative to incarceration (ATI) programs. https://www.criminaljustice.ny.gov/opca/ati_description.htm.

26.

NYC Mayor’s Office of Criminal Justice. (n.d.). Alternatives to incarceration. https://criminaljustice.cityofnewyork.us/reports/alternatives-to-incarceration-program-guide/.

27.

Robertson

A. A.

, St Lawrence

J. S.

, & McCluskey

D. L

. (2012). HIV/STI risk behavior of drug court participants. Journal of Offender Rehabilitation, 51(7), 453–473. 10.1080/10509674.2012.702715

28.

Spaulding

A. C.

, & Thomas

D. L

. (2012). Screening for HCV infection in jails. JAMA, 307(12), 1259–1260. 10.1001/jama.2012.374

29.

Yanes‐Lane

, Dussault

, Linthwaite

, Cox

, Klein

M. B.

, Sebastiani

, Lebouché

, & Kronfli

. (2020). Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review. Journal of Viral Hepatitis, 27(2), 205–220. 10.1111/jvh.13220

Testing and Linkage to Hepatitis C Care From Alternative-to-Incarceration Programs: The Right Place? The Right Time?

Abstract

Keywords

Get full access to this article

References